|
2023
|
Invention
|
Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides.
Disclosed are sulfonamide compoun... |
|
2022
|
Invention
|
Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides. Disclosed are sulfonamide compound... |
|
2020
|
Invention
|
N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as gpr17 modulators for treatin... |
|
2019
|
Invention
|
Substituted alkoxypyridinyl indolsulfonamides. The present application relates to alkoxy-substitu... |
|
|
Invention
|
Pyridinyl and pyrazinyl-(asa)indolsulfonamides. The present invention relates to pyridinyl and py... |
|
|
Invention
|
Pyridinyl and pyrazinyl-(aza)indolsulfonamides. The present invention relates to pyridinyl and py... |
|
|
Invention
|
Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of r... |
|
2018
|
Invention
|
Daily formulation of lacosamide.
A modified release formulation of lacosamide suitable for once-... |
|
|
Invention
|
Lacosamide controlled release formulation.
A modified release formulation of lacosamide suitable... |
|
2017
|
Invention
|
(aza)indole-, benzothiophene-, and benzofuran-3-sulfonamides. Disclosed are sulfonamide compounds... |
|
|
Invention
|
(aza)indole-, benzothiophene-, and benzofuran-3-sulfonamides. Disclosed are compounds of Formula ... |
|
|
G/S
|
Scientific, nautical, surveying, photographic,
cinematographic, optical, weighing, measuring, si... |
|
|
Invention
|
Use of rotigotine for treating the restless leg syndrome.
This invention relates to the use of r... |
|
|
G/S
|
Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, sig... |
|
2016
|
G/S
|
Providing educational services and resources via a website to health care providers and patients ... |
|
|
G/S
|
Arranging and Conducting of seminars and workshops in the medical field. |
|
2015
|
Invention
|
Process for preparing lacosamide. The present invention provides a process for the preparation of... |
|
|
Invention
|
Method for adjusting the release of active agent in a transdermal delivery system. Use of an addi... |
|
|
Invention
|
Transdermal delivery system including an interface mediator. Transdermal therapeutic system for t... |
|
|
Invention
|
Transdermal delivery system containing rotigotine. Transdermal therapeutic system for the transde... |
|
|
Invention
|
Anticonvulsant combination therapy. The present invention is directed to a pharmaceutical composi... |
|
2014
|
Invention
|
Pharmaceutical composition comprising lacosamide and levetiracetam.
The present application rela... |
|
|
Invention
|
Pharmaceutical composition comprising lacosamide and levetiracetam. The present application relat... |
|
|
Invention
|
Formulation of lacosamide.
A modified release formulation of lacosamide. |
|
|
Invention
|
Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine... |
|
|
Invention
|
Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis... |
|
|
Invention
|
Methods of treating refractory repetitive seizures.
The present invention is directed to the use... |
|
|
Invention
|
Methods of treating epileptogenesis.
The present invention is directed to the use of a class of ... |
|
2013
|
Invention
|
Micrornas as therapeutics and biomarkers for epilepsy. The present invention relates to a pharmac... |
|
|
Invention
|
Multi-day patch for the transdermal administration of rotigotine. The present invention relates t... |
|
|
Invention
|
Method of treating diseases that respond to therapy by dopamine or dopamine agonists. The inventi... |
|
|
Invention
|
Methods for treating channelopathies.
The present invention is directed to the use of a class of... |
|
|
Invention
|
Pharmaceutical compositions comprising fesoterodine. The present application relates to a pharmac... |
|
|
G/S
|
Telecommunications. Education; Providing of training; Entertainment; Sporting and cultural activi... |
|
2012
|
Invention
|
Transdermal therapeutic system with a low tendency to spontaneously crystallize.
The present inv... |
|
|
Invention
|
Transdermal therapeutic system with a low tendency to spontaneously crystallize. The invention re... |
|
|
Invention
|
Rotigotine in the treatment of hemispatial neglect and other deficits following stroke. The prese... |
|
|
Invention
|
Anticonvulsant combination therapy. A method for alleviating and/or treating epileptic seizures c... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of the central nervous system, namely Parkinson's d... |
|
2011
|
Invention
|
Daily formulation of lacosamide. A modified release formulation of lacosamide suitable for once-d... |
|
|
Invention
|
Process for the preparation of amino acid derivatives. 3 are as defined for compounds of formula ... |
|
|
Invention
|
Process for the preparation of nitrogen substituted aminotetralins derivatives. 3 are as defined ... |
|
|
Invention
|
Process for the preparation of nitrogen substituted aminotetralins derivatives. The present inven... |
|
2009
|
G/S
|
Pharmaceutical preparations and substances for the treatment of diseases of the central nervous s... |
|
|
G/S
|
Pharmaceutical products and substances used to treat
diseases of the central nervous system. Pri... |
|
2008
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of central nervous system diseases. |
|
|
G/S
|
Pharmaceutical preparations and substances for treating the central nervous system. Printed infor... |
|
|
G/S
|
Pharmaceutical preparations and substances for treating the central nervous system. Printed matte... |
|
2006
|
G/S
|
Pharmaceutical preparations and substances. |
|
2005
|
G/S
|
Pharmaceutical preparations containing the active substance rotigotine for treating restless leg ... |
|
2003
|
G/S
|
Pharmaceutical preparations and substances for treating the central nervous system. |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES, ... |
|
2000
|
G/S
|
Pharmaceutical preparations and substances for the treatment of central nervous system diseases, ... |
|
|
G/S
|
Pharmaceutical products. |
|
1997
|
G/S
|
Médicaments, produits chimiques pour la médecine et
l'hygiène, drogues pharmaceutiques. |
|
1996
|
G/S
|
Medicines, chemical products for medical and sanitary use,
pharmaceutical drugs. |
|
1994
|
G/S
|
Produits pharmaceutiques, vétérinaires et hygiéniques;
substances diététiques à usage médical, a... |
|
1986
|
G/S
|
Médicaments pour le traitement des maladies
cardiovasculaires. |
|
1954
|
G/S
|
Medicines. |
